Additive Efficacy of Physical Activity Program in Hypthyroidism Elder Females With Glaucoma and Fatty Liver Issues
1 other identifier
interventional
40
1 country
1
Brief Summary
additive efficacy of physical activity program in hypthyroidism in elder females with glaucoma and fatty liver issues was not investigated
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2026
CompletedFirst Submitted
Initial submission to the registry
May 9, 2026
CompletedFirst Posted
Study publicly available on registry
May 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2026
May 20, 2026
May 1, 2026
9 months
May 9, 2026
May 14, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
intraocular pressure
it will be assessed in both eyes
6 months
Secondary Outcomes (13)
body mass index
6 months
waist circumfrence
6 months
systolic blood pressure
6 months
diastolic blood pressure
6 months
glaucoma assocaited life quality survey
6 months
- +8 more secondary outcomes
Study Arms (2)
group number 1
EXPERIMENTALhypthyroidism elder females (n=20) with glaucoma and fatty liver issues recive their levothyroxine and physical activity program on treadmill thrice weekly for 6 month
group number 2
ACTIVE COMPARATORhypthyroidism elder females (n=20) with glaucoma and fatty liver issues will recive their levothyroxine only
Interventions
hypthyroidism elder females (n=20) with glaucoma and fatty liver issues that will recive their levothyroxine and physical activity program on treadmill thrice weehly for 6 month
hypthyroidism elder females (n=20) with glaucoma and fatty liver issues that will recive their levothyroxine only
Eligibility Criteria
You may qualify if:
- subclinical hypothrodism (significant form)
- primary opened angle gaulcoma in both eyes with ocular hypertension in both eyes )(high-tension typed glaucoma)
- fatty liver (non alcholic type)
- elder females
You may not qualify if:
- respiratory issues
- cardiac issues
- renal issues
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University
Dokki, Giza Governorate, 11432, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ali MA Ismail, lecturer
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of physical therapy for Cardiovascular, Respiratory disorder and Geriatrics, Faculty of Physical Therapy, Cairo University
Study Record Dates
First Submitted
May 9, 2026
First Posted
May 20, 2026
Study Start
March 15, 2026
Primary Completion (Estimated)
December 15, 2026
Study Completion (Estimated)
December 15, 2026
Last Updated
May 20, 2026
Record last verified: 2026-05